Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07459452) titled 'Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis' on Feb. 27.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Jemincare
Condition:
Perennial Allergic Rhinitis
Intervention:
Biological: JYB1904
Biological: JYB1904
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 2026
Target Sample Size: 135
To know more, visit https://clinicaltrials.gov/study/NCT07459452
Published ...